- Home
- Publications
- Publication Search
- Publication Details
Title
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-09-10
DOI
10.3389/fonc.2018.00367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The importance of the vascular endothelial barrier in the immune-inflammatory response induced by radiotherapy
- (2018) Olivier Guipaud et al. BRITISH JOURNAL OF RADIOLOGY
- High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma
- (2018) Andreas Seeber et al. CANCER SCIENCE
- Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy
- (2018) Angela Rita Elia et al. CLINICAL CANCER RESEARCH
- Contribution of Tumor Endothelial Cells in Cancer Progression
- (2018) Kyoko Hida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer
- (2018) Hongjun Zhu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Increased vessel perfusion predicts the efficacy of immune checkpoint blockade
- (2018) Xichen Zheng et al. JOURNAL OF CLINICAL INVESTIGATION
- Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
- (2018) Xiaolei Li et al. Journal of Hematology & Oncology
- Indoleamine 2, 3-dioxygenase regulation of immune response (Review)
- (2018) Hao Wu et al. Molecular Medicine Reports
- The dark side of tumor-associated endothelial cells
- (2018) Francesco De Sanctis et al. SEMINARS IN IMMUNOLOGY
- Cancer Radiosensitizers
- (2018) Hao Wang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Increased tumor vascularization is associated with the amount of immune competent PD‑1 positive cells in testicular germ cell tumors
- (2018) Lukas Jennewein et al. Oncology Letters
- Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile
- (2018) Annabel Meireson et al. Oncotarget
- A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma
- (2018) Lukas Krähenbühl et al. NEOPLASIA
- Association Between Programmed Death-Ligand 1 Expression and the Vascular Endothelial Growth Factor Pathway in Angiosarcoma
- (2018) Sanjay P. Bagaria et al. Frontiers in Oncology
- The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
- (2017) Lieve Brochez et al. EUROPEAN JOURNAL OF CANCER
- Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
- (2017) Keehoon Jung et al. JOURNAL OF CLINICAL INVESTIGATION
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
- (2017) Martina Schmittnaegel et al. Science Translational Medicine
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model
- (2017) Colette A. Bichsel et al. Scientific Reports
- Barriers to Radiation-Induced In Situ Tumor Vaccination
- (2017) Erik Wennerberg et al. Frontiers in Immunology
- Integration of pro- and anti-angiogenic signals by endothelial cells
- (2017) Shideh Kazerounian et al. Journal of Cell Communication and Signaling
- Radiation-induced changes in the glycome of endothelial cells with functional consequences
- (2017) Cyprien Jaillet et al. Scientific Reports
- Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
- (2016) Ann Ager et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
- (2016) Haidong Tang et al. CANCER CELL
- The Complexity of Translating Anti-angiogenesis Therapy from Basic Science to the Clinic
- (2016) Weilan Ye DEVELOPMENTAL CELL
- Transcriptional control of endothelial energy
- (2016) Christer Betsholtz NATURE
- FOXO1 couples metabolic activity and growth state in the vascular endothelium
- (2016) Kerstin Wilhelm et al. NATURE
- Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging
- (2016) Hyun Jung Koo et al. PLoS One
- Ionizing Radiation-Induced Endothelial Cell Senescence and Cardiovascular Diseases
- (2016) Yingying Wang et al. RADIATION RESEARCH
- Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
- (2016) N. N. Rahbari et al. Science Translational Medicine
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature within the Process of Vascular Remodeling: Cellular Basis, Clinical Relevance, and Implications for Stem Cell Therapy
- (2016) Diana Klein Stem Cells International
- Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment
- (2016) Natacha Leroi et al. Frontiers in Pharmacology
- Modulation of inflammation by low and high doses of ionizing radiation: Implications for benign and malign diseases
- (2015) Benjamin Frey et al. CANCER LETTERS
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy
- (2015) Everett J. Moding et al. Science Translational Medicine
- Broad targeting of angiogenesis for cancer prevention and therapy
- (2015) Zongwei Wang et al. SEMINARS IN CANCER BIOLOGY
- In vivo evidence for an endothelium-dependent mechanism in radiation-induced normal tissue injury
- (2015) Emilie Rannou et al. Scientific Reports
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
- (2015) Rikke B. Holmgaard et al. Cell Reports
- Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors
- (2015) D Klein et al. Oncogenesis
- T Lymphocyte–Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific Immunity
- (2015) Christopher V. Carman et al. Frontiers in Immunology
- Targeting the indoleamine 2,3-dioxygenase pathway in cancer
- (2015) Yong Wha Moon et al. Journal for ImmunoTherapy of Cancer
- Radiotherapy Combined with the Immunocytokine L19-IL2 Provides Long-lasting Antitumor Effects
- (2015) C. M. L. Zegers et al. CLINICAL CANCER RESEARCH
- Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
- (2014) I. Chevolet et al. BRITISH JOURNAL OF DERMATOLOGY
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Endothelial Dysfunction in Chronic Inflammatory Diseases
- (2014) Curtis Steyers et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Endothelial Microparticles Interact with and Support the Proliferation of T Cells
- (2014) Julie Wheway et al. JOURNAL OF IMMUNOLOGY
- Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
- (2014) Bernardo Tavora et al. NATURE
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
- (2014) B. Schrand et al. Cancer Immunology Research
- Tumor Interstitial Fluid Pressure—A Link between Tumor Hypoxia, Microvascular Density, and Lymph Node Metastasis
- (2014) Einar K. Rofstad et al. NEOPLASIA
- Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
- (2014) Encouse B Golden et al. OncoImmunology
- Linking endothelial dysfunction with endothelial cell activation
- (2013) James K. Liao JOURNAL OF CLINICAL INVESTIGATION
- An evolving new paradigm: endothelial cells – conditional innate immune cells
- (2013) Jietang Mai et al. Journal of Hematology & Oncology
- Radiation-induced angiogenic signaling pathway in endothelial cells obtained from normal and cancer tissue of human breast
- (2013) E-T Oh et al. ONCOGENE
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma
- (2013) Laura M. Alwan et al. Targeted Oncology
- Tumor Endothelial Cells
- (2013) A. C. Dudley Cold Spring Harbor Perspectives in Medicine
- Heterogeneity of Tumor Endothelial Cells
- (2012) Noritaka Ohga et al. AMERICAN JOURNAL OF PATHOLOGY
- Prospective Trial of Synchronous Bevacizumab, Erlotinib, and Concurrent Chemoradiation in Locally Advanced Head and Neck Cancer
- (2012) David S. Yoo et al. CLINICAL CANCER RESEARCH
- Targeting TNF- to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy
- (2012) A. Calcinotto et al. JOURNAL OF IMMUNOLOGY
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Endothelial activation, dysfunction and permeability during severe infections
- (2011) Warren L Lee et al. CURRENT OPINION IN HEMATOLOGY
- Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab
- (2011) Philip Weißhardt et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Participation of blood vessel cells in human adaptive immune responses
- (2011) Jordan S. Pober et al. TRENDS IN IMMUNOLOGY
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors
- (2009) Tomoshige Akino et al. AMERICAN JOURNAL OF PATHOLOGY
- Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
- (2009) Konstantin Gaengel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Interstitial Fluid Pressure as a Prognostic Factor in Cervical Cancer Following Radiation Therapy
- (2009) S.-G. Yeo et al. CLINICAL CANCER RESEARCH
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- The neovasculature homing motif NGR: more than meets the eye
- (2008) A. Corti et al. BLOOD
- Vascular normalization in Rgs5-deficient tumours promotes immune destruction
- (2008) Juliana Hamzah et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started